Abstract

Oncolytic adenoviruses is the use of genetically engineered adenoviruses that specifically target and destroy tumor cells via their cytolytic replication cycle and also may provide a highly efficient means of delivering therapeutic genes to tumor,which combines the advantages of gene therapy and viral therapy. Adenovirus vector Ad5- hTERT -E1Arep (A telomerase gene-derived promoter was used to control the expression of the E1A gene ) was constructed and cytosine deaminase(CD)/herpes simplex type 1 thymidine kinase(HSV-1 TK) fusion gene were inserted into Ad5- hTERT -E1Arep to form Ad5- hTERT -E1Arep -CD/TK. The (5- FC+GCV) produg enhanced the tumor cell-specific cytopathic effects of the Ad5- hTERT -E1Arep -CD/TK against A549 human lung cancer cell.Neither the Ad5- hTERT -E1Arep-CD/TK nor suicide gene system showed significant toxicity to normal human fibroblast or epithelial cells. Furthermore,we demonstrated that the survival of A549 human lung cancer xenografted mice treated with Ad5- hTERT -E1Arep -CD/TK alone was prolonged.Therapeutic outcome was dramatically improved with systemic administration of double prodrug (5-FC+GCV) therapy. These data demonstrate that combination of oncolytic adenoviruses with the (CD+TK)/(5- FC+GCV) suicide gene system resulted in a striking improvement in treatment efficacy.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.